A Systematic Review of the Prevalence of Schizophrenia

Cited by (1,003)

Items 201–300 of 1,003

1. Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families
   Juho Wedenoja, Anu Loukola, Annamari Tuulio‐Henriksson, Tiina Paunio, Jesper Ekelund, Kaisa Silander, Teppo Varilo, Kauko V Heikkila, Jaana Suvisaari, Timo Partonen et al. · 2007 · Molecular Psychiatry
2. Trends and Significance of VRE Colonization in the ICU: A Meta-Analysis of Published Studies
   Panayiotis D. Ziakas, Rachana Thapa, Louis B. Rice, Eleftherios E Mylonakis · 2013 · PLoS ONE
3. Meta-analyses of Blood Homocysteine Levels for Gender and Genetic Association Studies of the MTHFR C677T Polymorphism in Schizophrenia
   A. Nishi, Shusuke Numata, Atsushi Tajima, Makoto Kinoshita, Kumiko Kikuchi, Shinji Shimodera, Masahito Tomotake, Kazutaka Ohi, Ryota Hashimoto, Issei Imoto et al. · 2014 · Schizophrenia Bulletin
4. A population-level metric for gambling-related harm
   Matthew Browne, Nancy L. Greer, Vijay Rawat, Matthew Rockloff · 2017 · International Gambling Studies
5. Schizophrenia: a disorder of broken brain bioenergetics
   Nicholas Henkel, Xiajoun Wu, Sinead Marie O'Donovan, Emily A. Devine, Jessica M. Jiron, Laura M. Rowland, Zóltan Sarnyai, Amy J. Ramsey, Zhexing Wen, Margaret Hahn et al. · 2022 · Molecular Psychiatry
6. Optimal Extent of Dopamine D2 Receptor Occupancy by Antipsychotics for Treatment of Dopamine Supersensitivity Psychosis and Late-Onset Psychosis
   Masaomi Iyo, Shigenori Tadokoro, Nobuhisa Kanahara, Tasuku Hashimoto, Tomihisa Niitsu, Hiroyuki Watanabe, Kenji Hashimoto · 2013 · Journal of Clinical Psychopharmacology
7. Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis
   Dan Chisholm · 2008 · Bulletin of the World Health Organization
8. The Surprisingly Rich Contours of Schizophrenia Epidemiology
   John Joseph McGrath · 2007 · Archives of General Psychiatry
9. A unifying hypothesis of schizophrenia: Abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction
   Dennis K. Kinney, Kathryn Hintz, Erika M. Shearer, Daniel H. Barch, Catherine A. Riffin, Katherine Whitley, Robert N. Butler · 2009 · Medical Hypotheses
10. A preliminary analysis of association between the down-regulation of microRNA-181b expression and symptomatology improvement in schizophrenia patients before and after antipsychotic treatment
    Hongtao Song, Xinyang Sun, Liang Zhang, Lin Zhao, Zhong-min Guo, Huimin Fan, Aifang Zhong, Wei Niu, Yunhua Dai, Li-Yi Zhang et al. · 2014 · Journal of Psychiatric Research
11. Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
    John Yin, Alasdair M. Barr, Alfredo Ramos‐Miguel, Ric M. Procyshyn · 2016 · Current Neuropharmacology
12. Biological hypotheses, risk factors, and biomarkers of schizophrenia
    Zdeněk Fišar · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
13. Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population
    Wing Chung Chang, Corine Sau Man Wong, Eric Yu Hai Chen, LINDA C. W. LAM, Wai Chi Chan, Roger Ng, Se Fong Hung, Eric F. C. Cheung, Pak Chung Sham, Helen Fung Kum Chiu et al. · 2017 · Schizophrenia Bulletin
14. Perineuronal nets and schizophrenia: The importance of neuronal coatings
    Bitanihirwe, Byron K.Y., Woo, Tsung-Ung W. · 2014 · Neuroscience & Biobehavioral Reviews
15. The genomics of schizophrenia: update and implications
    Paola Giusti‐Rodríguez, Patrick F. Sullivan · 2013 · Journal of Clinical Investigation
16. nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives
    Vinay Parikh, Munir Gunes Kutlu, Thomas J. Gould · 2016 · Schizophrenia Research
17. INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia
    Robert Ali McCutcheon, Toby Pillinger, Ioana Varvari, Sean Halstead, Olatunde Olayinka Ayinde, Nicolas Andres Crossley, Christoph Ulrich Correll, Margaret Hahn, Oliver David Howes, John Michael Kane et al. · 2025 · The Lancet Psychiatry
18. Schizophrenia, Psychiatric Genetics, and Darwinian Psychiatry: An Evolutionary Framework
    Godfrey D. Pearlson, Bradley S. Folley · 2007 · Schizophrenia Bulletin
19. The connection between microbiome and schizophrenia
    Golofast, Bogdana, Vales, Karel · 2020 · Neuroscience & Biobehavioral Reviews
20. The role of reelin in adult synaptic function and the genetic and epigenetic regulation of the reelin gene
    Jonathan M. Levenson, Shenfeng Qiu, Edwin J. Weeber · 2008 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
21. NCAM1 and Neurocognition in Schizophrenia
    Patrick F. Sullivan, Richard S.E. Keefe, Leslie A. Lange, Ethan M. Lange, T. Scott Stroup, Jeffrey Alan Lieberman, Patricia F. Maness · 2006 · Biological Psychiatry
22. Estimating clinically relevant mental disorders in a rural and an urban setting in postconflict Timor Leste
    Silove, Derrick, Bateman, Catherine Robina, Brooks, Robert T., Fonseca, C. Amaral Zulmira, Steel, Zachary, Rodger, James, Soosay, Ian, Fox, Greg, Patel, Vikram, Bauman, Adrian · 2008 · Archives of General Psychiatry
23. Packages of Care for Schizophrenia in Low- and Middle-Income Countries
    Mari, Jair de Jesus, Razzouk, Denise, Thara, Rangaswamy, Eaton, Julian, Thornicroft, Graham · 2009 · PLoS Medicine
24. Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data
    Kin Ying Mok, Una‐Marie Sheerin, Javier Simón‐Sánchez, Afnan S. Salaka, Lucy A. Chester, Valentina Escott‐Price, Kiran K. Mantripragada, Karen A. Doherty, Alastair John Noyce, Niccolò Emanuele Mencacci et al. · 2016 · The Lancet Neurology
25. Prevalence of intimate partner violence perpetration among military populations: A systematic review and meta-analysis
    Jamie Kwan, K. Sparrow, Emma Facer-Irwin, Gursimran Thandi, Nicola T. Fear, Deirdre MacManus · 2020 · Aggression and Violent Behavior
26. Risk factors for suicide in schizophrenia: Findings from a Swedish population-based case-control study
    Johan Reutfors, Lena Brandt, Erik Gunnar Jönsson, Anders Ekbom, Pär Sparén, Urban Ösby · 2009 · Schizophrenia Research
27. Exome Sequencing in 53 Sporadic Cases of Schizophrenia Identifies 18 Putative Candidate Genes
    Michel Guipponi, Federico Andrea Santoni, Vincent Setola, Corinne Gehrig, Maud Rothärmel, Macarena Cuenca, Olivier Guillin, Dimitris G. Dikeos, Georgios Georgantopoulos, George N. Papadimitriou et al. · 2014 · PLoS ONE
28. Sex and schizophrenia: a review of gender differences
    Jara Falkenburg, Derek Kenneth Tracy · 2012 · Psychosis
29. A Systematic Review of the Effect of Probiotic Supplementation on Schizophrenia Symptoms
    Ng, Qin Xiang, Soh, Alex Yu Sen, Venkatanarayanan, Nandini, Ho, Collin Yih Xian, Lim, Donovan Yutong, Yeo, Wee-Song · 2019 · Neuropsychobiology
30. Progress and Future Directions in Research on the Psychosis Prodrome
    Kristen A. Woodberry, Daniel I. Shapiro, Caitlin Bryant, Larry J. Seidman · 2016 · Harvard Review of Psychiatry
31. Prevalence of schizophrenia in China between 1990 and 2010.
    Kit Yee Chan, Fei-Fei Zhao, Shijiao Meng, Sandro Demaio, Craig Reed, Evropi Τheodoratou, Harry J. Campbell, Wei Wang, Igor Rudan · 2015 · PubMed Central
32. Familial Aggregation and Heritability of Schizophrenia and Co-aggregation of Psychiatric Illnesses in Affected Families
    I‐Jun Chou, Chang‐Fu Kuo, Yu‐Shu Huang, Matthew J. Grainge, Ana Maria Valdes, Lai‐Chu See, Kuang‐Hui Yu, Shue‐Fen Luo, Lu-Shuang Huang, Wen-Yi Tseng et al. · 2016 · Schizophrenia Bulletin
33. Cortical Inhibition, Excitation, and Connectivity in Schizophrenia: A Review of Insights From Transcranial Magnetic Stimulation
    Nigel C. Rogasch, Zafiris Jeff Daskalakis, Paul Bernard Fitzgerald · 2013 · Schizophrenia Bulletin
34. Poverty, inequality and the treated incidence of first-episode psychosis
    Jonathan Kenneth Burns, Tonya M. Esterhuizen · 2008 · Social Psychiatry and Psychiatric Epidemiology
35. Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia
    Jari K. Haukka, Jari Tiihonen, Tommi Härkänen, Jouko K Lönnqvist · 2008 · Pharmacoepidemiology and Drug Safety
36. Triggers for Violent Criminality in Patients With Psychotic Disorders
    Amir Sariaslan, Paul Lichtenstein, Henrik Larsson, Seena Fazel · 2016 · JAMA Psychiatry
37. Narrative identity in the psychosis spectrum: A systematic review and developmental model
    Cowan, Henry R., Mittal, Vijay A., McAdams, Dan P. · 2021 · Clinical Psychology Review
38. Using the tools of genetic epidemiology to understand sex differences in neuropsychiatric disorders
    Merikangas, Alison K., Almasy, Laura · 2020 · Genes, Brain and Behavior
39. Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study
    Bing Cao, Dongfang Wang, Zihang Pan, Elisa Macedo Brietzke, Roger S. McIntyre, Natalie Musial, Rodrigo Barbachan Mansur, Mehala Subramanieapillai, Jing Zeng, Ninghua Huang et al. · 2019 · Translational Psychiatry
40. Mortality among People with Severe Mental Disorders Who Reach Old Age: A Longitudinal Study of a Community-Representative Sample of 37892 Men
    Osvaldo P. Almeida, Graeme J. Hankey, Bu Beng Yeap, Jonathan Golledge, Paul E. Norman, Leon A Flicker · 2014 · PLoS ONE
41. The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants
    Bryan J. Mowry, Jacob Gratten · 2012 · Molecular Psychiatry
42. Animal models of gene–environment interaction in schizophrenia: A dimensional perspective
    Yavuz Ayhan, Ross McFarland, Mikhail V. Pletnikov · 2015 · Progress in Neurobiology
43. Lay health supporters aided by mobile text messaging to improve adherence, symptoms, and functioning among people with schizophrenia in a resource-poor community in rural China (LEAN): A randomized controlled trial
    Dong Roman Xu, Shuiyuan Xiao, Hua He, Eric D. Caine, Stephen S. Gloyd, Jane M. Simoni, James P. Hughes, Juan Nie, Meijuan Lin, Wenjun He et al. · 2019 · PLoS Medicine
44. The neurobiology of social environmental risk for schizophrenia: an evolving research field
    Ceren Akdeniz, Heike Tost, Andreas Meyer‐Lindenberg · 2014 · Social Psychiatry and Psychiatric Epidemiology
45. Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies
    Brandon Scott Pruett, James H. Meador‐Woodruff · 2020 · Schizophrenia Research
46. Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia
    Iain Mathieson, Marcus Robert Munafo, Jonathan Flint · 2011 · Molecular Psychiatry
47. Functional near infra-red spectroscopy (fNIRS) in schizophrenia: A review
    Vijay Kumar, Venkataram Shivakumar, Harleen Chhabra, Anushree Bose, Ganesan Venkatasubramanian, Bangalore N. Gangadhar · 2017 · Asian Journal of Psychiatry
48. Qualitative Sociology Review
    2021 · Qualitative Sociology Review
49. Genetic variants in long non-coding RNA MIAT contribute to risk of paranoid schizophrenia in a Chinese Han population
    Shuquan Rao, Huiling Hu, Ning Ye, Yan Shen, Qi Xu · 2015 · Schizophrenia Research
50. Epidemiology of schizophrenia and its management over 8-years period using real-world data in Spain
    Alejandro Orrico‐Sánchez, Mónica López‐Lacort, Cintia Muñoz-Quiles, Gabriel Sanfélix‐Gimeno, Javier Díez‐Domingo · 2020 · BMC Psychiatry
51. Misdiagnosis, detection rate, and associated factors of severe psychiatric disorders in specialized psychiatry centers in Ethiopia
    Getinet Ayano, Sileshi Demelash, Zegeye Yohannes, Kibrom Haile, Mikiyas Tullu, Dawit Getachew Assefa, Abel Mekonnen Tesfaye, Kelemua Haile, Melat Solomon, Asrat Chaka et al. · 2021 · Annals of General Psychiatry
52. Novel Synthetic Routes to Prepare Biologically Active Quinoxalines and Their Derivatives: A Synthetic Review for the Last Two Decades
    Hena Khatoon, Emilia Abdulmalek · 2021 · Molecules
53. Geographic variation and sociodemographic characteristics of psychotic disorders in Finland
    J. Perälä, Suoma S. Saarni, Aini I. Ostamo, Sami P. Pirkola, Jari K. Haukka, Tommi Härkänen, Seppo V. P. Koskinen, Jouko K Lönnqvist, J Suvisaari · 2008 · Schizophrenia Research
54. Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons
    Christa Whelan Habela, Hongjun Song, Guo‐li Ming · 2015 · Molecular and Cellular Neuroscience
55. Morbidity and mortality in schizophrenia with comorbid substance use disorders
    Markku Lähteenvuo, Albert Batalla, Jurjen Justin Luykx, Ellenor Mittendorfer‐Rutz, Antti J. Tanskanen, Jari Tiihonen, Heidi T. Taipale · 2021 · Acta Psychiatrica Scandinavica
56. Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making
    Jan Volavka, Leslie Citrome · 2009 · Expert Opinion on Pharmacotherapy
57. An emerging role for mitochondrial dynamics in schizophrenia
    Kyle H. Flippo, Stefan Strack · 2017 · Schizophrenia Research
58. New directions in the epidemiology of schizophrenia
    John Joseph McGrath, Ezra Susser · 2009 · The Medical Journal of Australia
59. The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research
    Conrad Osamede Iyegbe, Desmond Campbell, Amy W. Butler, Olesya Ajnakina, Pak Chung Sham · 2014 · Social Psychiatry and Psychiatric Epidemiology
60. Family caregivers and outcome of people with schizophrenia in rural China: 14-year follow-up study
    Mao‐Sheng Ran, CHERYL HIU-KWAN CHUI, Irene Yin-Ling Wong, Wen-Jun Mao, Fu-Rong Lin, Bo Liu, Clw Chan · 2016 · Social Psychiatry and Psychiatric Epidemiology
61. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions
    Hayley F. North, Jason M. Bruggemann, Vanessa Cropley, Vaidy Swaminathan, Suresh Sundram, Rhoshel Lenroot, Avril M. Pereira, Andrew Zalesky, Chad Bousman, Christos Pantelis et al. · 2021 · European Archives of Psychiatry and Clinical Neuroscience
62. Prevalence of DSM-IV major mental disorders among Korean adults: A 2006 National Epidemiologic Survey (KECA-R)
    Maeng Je Cho, Sung Man Chang, Young Moon Lee, Ahn Bae, Joon Ho Ahn, Jung-Woo Son, Jin Pyo Hong, Jae Nam Bae, Dong Woo Lee, Seong‐Jin Cho et al. · 2010 · Asian Journal of Psychiatry
63. Impact of atypical long-acting injectable versus oral antipsychotics on rehospitalization rates and emergency room visits among relapsed schizophrenia patients: a retrospective database analysis
    Marie‐Hélène Lafeuille, François Laliberté-Auger, Patrick Lefèbvre, Christian Frois, John M. Fastenau, Mei Sheng Duh · 2013 · BMC Psychiatry
64. What does the broken brain say to the neuroscientist? Oscillations and connectivity in schizophrenia, Alzheimer's disease, and bipolar disorder
    Ertuğrul Başar, Christina Schmiedt‐Fehr, Birgit Mathes, Banu Femir, Derya Durusu Emek‐Savaş, Emine Elif Tülay, D. Tan, A. Düzgün, Bahar Güntekin, Ayşegül Özerdem et al. · 2015 · International Journal of Psychophysiology
65. Ethnic origin and increased risk for schizophrenia in immigrants to countries of recent and longstanding immigration
    Marie-José Dealberto · 2010 · Acta Psychiatrica Scandinavica
66. Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness
    Derek J. Fisher, Alain Labelle, Verner Knott · 2012 · Schizophrenia Research
67. Oxidative Stress in Schizophrenia: Pathogenetic and Therapeutic Implications
    Jeffrey K. Yao, Ravinder D Reddy · 2011 · Antioxidants and Redox Signaling
68. The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum
    Lang, Raynell, Hogan, Brenna, Zhu, Jiafeng, McArthur, Kristen, Lee, Jennifer, Zandi, Peter, Nestadt, Paul, Silverberg, Michael J., Parcesepe, Angela M., Cook, Judith A. et al. · 2023 · AIDS
69. Mental health is biological health: Why tackling “diseases of the mind” is an imperative for biological anthropology in the 21st century
    Kristen Syme, Edward H. Hagen · 2019 · American Journal of Physical Anthropology
70. 20‐year trajectories of positive and negative symptoms after the first psychotic episode in patients with schizophrenia spectrum disorder: results from the OPUS study
    Marie Stefanie Kejser Starzer, Helene Gjervig Hansen, Carsten Rygaard Hjorthøj, Nikolai Albert, Merete Nordentoft, Trine Madsen · 2023 · World Psychiatry
71. Discovery of 4-(5-Methyloxazolo[4,5- b ]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders in Schizophrenia: Synthesis, SAR Development, and in Vivo Efficacy in Cognition Models
    Christopher J. O’Donnell, Bruce N. Rogers, Brian S. Bronk, Dianne K. Bryce, Jotham W. Coe, Karen K. Cook, Allen J. Duplantier, Edelweiss Evrard, Mihály Hajós, William E. Hoffmann et al. · 2009 · Journal of Medicinal Chemistry
72. Incidence and prevalence of mental disorders among immigrants and native Finns: a register-based study
    Niina Markkula, Venla Lehti, Mika Gissler, Jaana Suvisaari · 2017 · Social Psychiatry and Psychiatric Epidemiology
73. The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study
    Citrome, Leslie, Ota, Ai, Nagamizu, Kazuhiro, Perry, Pamela, Weiller, Emmanuelle, Baker, Ross A. · 2016 · International Clinical Psychopharmacology
74. Five-year clinical course and outcome of schizophrenia in Ethiopia
    Solomon Teferra, Teshome Shibre, Abebaw Fekadu, Girmay Medhin, Asfaw Wakwoya, Atalay Alem, Lars H. Jacobsson · 2011 · Schizophrenia Research
75. Stimulus-Selective Response Plasticity in the Visual Cortex: An Assay for the Assessment of Pathophysiology and Treatment of Cognitive Impairment Associated with Psychiatric Disorders
    Samuel F. Cooke, Mark F. Bear · 2011 · Biological Psychiatry
76. Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
    Jacqueline Sin, Debbie Spain, Marie Furuta, Trevor Murrells, Ian James Norman · 2017 · Cochrane Database of Systematic Reviews
77. Metabolic Profiling Identifies Phospholipids as Potential Serum Biomarkers for Schizophrenia
    Wang, Dongfang, Cheng, Sunny Lihua, Fei, Qiang, Gu, Haiwei, Raftery, Daniel, Cao, Bing, Sun, Xiaoyu, Yan, Jingjing, Zhang, Chuanbo, Wang, Jingyu · 2019 · Psychiatry Research
78. In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
    Faith Borgan, Heikki Laurikainen, Mattia Veronese, Tiago Reis Marques, Merja Haaparanta‐Solin, Olof H. Solin, Tarik Dahoun, Maria Rogdaki, Raimo K. R. Salokangas, Max Karukivi et al. · 2019 · JAMA Psychiatry
79. Grey and white matter microstructure is associated with polygenic risk for schizophrenia
    Eva-Maria Stauffer, Richard A. I. Bethlehem, Varun Warrier, Graham K. Murray, Rafael Romero-García, Jakob Seidlitz, Edward Thomas Bullmore · 2021 · Molecular Psychiatry
80. Structural and Functional Deviations of the Hippocampus in Schizophrenia and Schizophrenia Animal Models
    David Wegrzyn, Georg Juckel, Andréas Faissner · 2022 · International Journal of Molecular Sciences
81. Evolutionary biology and anthropology suggest biome reconstitution as a necessary approach toward dealing with immune disorders
    William Parker, Jeff Ollerton · 2013 · Evolution Medicine and Public Health
82. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells
    Meiling Liu, Peng Zheng, Zhao Liu, Yi Xu, Jun Mu, Jing Guo, Ting Huang, Huaqing Meng, Peng Xie · 2014 · Molecular BioSystems
83. Serum trace element differences between Schizophrenia patients and controls in the Han Chinese population
    Lei Cai, Tianlu Chen, Jinglei Yang, Kejun Zhou, Xiaomei Yan, Wenzhong Chen, Liya Sun, Linlin Li, Shengying Qin, Peng Wang et al. · 2015 · Scientific Reports
84. Deep learning applied to electroencephalogram data in mental disorders: a systematic review
    de Bardeci, Mateo, Ip, Cheng Teng, Olbrich, Sebastian · 2021 · Biological Psychology
85. Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia
    Nicholas A Keks, Judy Hope, Darren Schwartz, Harold McLennan, David Copolov, Graham Nicholas Meadows · 2020 · CNS Drugs
86. Incidence and Persistence of Psychotic Experiences in the General Population: Systematic Review and Meta-Analysis
    Lorna Staines, Colm Healy, Felim Murphy, Jonah F. Byrne, Jennifer Murphy, Ian Kelleher, David Cotter, Mary D Cannon · 2023 · Schizophrenia Bulletin
87. Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment
    Henry A. Nasrallah, Rajiv Tandon, Matcheri S. Keshavan · 2011 · Epidemiology and Psychiatric Sciences
88. The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia
    Lilian Enríquez-Barreto, Miguel Morales · 2016 · Journal of Green Engineering
89. Toward recovery in schizophrenia: Current concepts, findings, and future research directions
    Toshiaki Onitsuka, Yoji Hirano, Takanobu Nakazawa, Kayo Ichihashi, Kenichiro Miura, Ken Inada, Ryo Mitoma, Norio Yasui‐Furukori, Ryota Hashimoto · 2022 · Psychiatry and Clinical Neurosciences
90. Positron Emission Tomography in Schizophrenia: A New Perspective
    Neva Patel, Nora S. Vyas, Basant K. Puri, Kuldip S. Nijran, ADIL M. AL-NAHHAS · 2010 · Journal of Nuclear Medicine
91. Do sleep abnormalities and misaligned sleep/circadian rhythm patterns represent early clinical characteristics for developing psychosis in high risk populations?
    Zanini, Marcio, Castro, Juliana, Coelho, Fernando Morgadinho, Bittencourt, Lia, Bressan, Rodrigo A., Tufik, Sergio, Brietzke, Elisa · 2013 · Neuroscience & Biobehavioral Reviews
92. Predictive waves in the autism-schizophrenia continuum: A novel biobehavioral model
    Luca Tarasi, Jelena Trajkovic, Stefano Diciotti, Giuseppe di Pellegrino, Francesca Ferri, Mauro Ursino, Vincenzo Romei · 2021 · Neuroscience & Biobehavioral Reviews
93. Blood–brain barrier dysfunction in brain diseases: Clinical experience
    Karl Schoknecht, Hadar Shalev · 2012 · Epilepsia
94. Cultural Aspects of Major Mental Disorders: A Critical Review from an Indian Perspective
    Biju Viswanath, Santosh K. Chaturvedi · 2012 · Indian Journal of Psychological Medicine
95. Three models of community mental health services In low-income countries
    Alex Cohen, Julian Eaton, Birgit Radtke, Christina George, Bro Manuel, Mary J De Silva, Vikram Patel · 2011 · International Journal of Mental Health Systems
96. Schizophrenia in the Offspring of Antenatally Depressed Mothers in the Northern Finland 1966 Birth Cohort: Relationship to Family History of Psychosis
    Pirjo H. Mäki, Tiina Taka-Eilola, Jouko Miettunen, Matti K. Isohanni, Peter Brian Jones, Graham K. Murray, Juha M. Veijola · 2009 · American Journal of Psychiatry
97. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients*
    James L. Karagianis, Diego Novick, Ján Pečeňák, Josep María Haro, Martin R.K Dossenbach, Tamás Treuer, William S. Montgomery, Richard Walton, Amanda J. Lowry · 2009 · International Journal of Clinical Practice
98. Toxoplasmosis and Polygenic Disease Susceptibility Genes: ExtensiveToxoplasma gondiiHost/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders
    Christopher Carter · 2013 · Journal of Pathogens
99. The Prevalence of Delusion-Like Beliefs Relative to Sociocultural Beliefs in the General Population
    Rachel Pechey, Peter W. Halligan · 2010 · Psychopathology
100. Pharmacotherapy for treatment-resistant schizophrenia
     Jeff Harrison, Meghan McIlwain, Amanda Wheeler, Russell · 2011 · Neuropsychiatric Disease and Treatment